Key facts
- It has raised $400K; the latest was Seed Round ($400K) in Aug 2025.
- Notable investors include Siddhi Capital, Meach Cove Capital, Branch Venture Group, Cellular Agriculture, Replicator VC.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for EdiMembre
- ·The full record, as it builds
Funding rounds
No funding rounds for EdiMembre are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About EdiMembre
Manufacturer of bioreactor-based cultivation tools designed for early-stage cellular agriculture research. The company incorporates edible hollow fiber scaffolding, bench-scale production capacity, structured tissue formation capabilities, and compatibility with cultivated meat prototypes, enabling food science laboratories and biotechnology researchers to simulate whole-cut textures, test growth conditions, and refine tissue engineering methods for alternative protein development.
- Sector
- Healthcare
- HQ
- Cambridge, MA, United States
- Founded
- 2025
- Employees
- 4
- Website
- edimembre.co/
- Ownership
- Privately Held (backing)
EdiMembre doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in EdiMembre shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on EdiMembre in its N-PORT filings yet. We sweep new filings monthly.